The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Novel Mechanism for Endothelial Dysfunction: Dysregulation of Dimethylarginine Dimethylaminohydrolase
Abstract
Background —Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). Plasma levels of ADMA are elevated in individuals with hypercholesterolemia or atherosclerosis. We postulated that reduced degradation of ADMA may play a role in the accumulation of ADMA in these individuals. Accordingly, we studied the effects of oxidized LDL (oxLDL) or tumor necrosis factor-α (TNF-α) on the accumulation of ADMA by transformed human umbilical vein endothelial cells (ECV304) and on the enzyme dimethylarginine dimethylaminohydrolase (DDAH), which degrades ADMA. Methods and Results —ECV304 were incubated with or without native LDL (100 μg/mL), oxLDL (100 μg/mL), or TNF-α (250 U/mL) for 48 hours. The concentration of ADMA in the conditioned medium was determined by high-performance liquid chromatography. Western blotting was performed to evaluate DDAH expression. We assayed DDAH activity by determining l -citrulline formation from ADMA. The addition of oxLDL or TNF-α to ECV304 significantly increased the level of ADMA in the conditioned medium. The effect of oxLDL or TNF-α was not due to a change in DDAH expression but rather to the reduction of DDAH activity. To determine whether dysregulation of DDAH also occurred in vivo, New Zealand White rabbits were fed normal chow or a high-cholesterol diet. Hypercholesterolemia significantly reduced aortic, renal, and hepatic DDAH activity. Conclusions —These results suggest that the endothelial vasodilator dysfunction observed in hypercholesterolemia may be due to reduced degradation of ADMA, the endogenous inhibitor of NOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Self-citationHigh-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis
Vallance, P., Leone, A., Calver, A., Collier, J., & Moncada, S. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199204002-00018 · Cited by 469
Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
Lerman, A., Burnett, J. C., Higano, S. T., McKinley, L. J., & Holmes, D. R. (1998) · Circulation · doi:10.1161/01.cir.97.21.2123 · Cited by 426
Khripach, V. A., Zhabinskii, V. N., & de Groot, A. E. (1999) · Brassinosteroids · doi:10.1016/b978-012406360-0/50004-6 · Cited by 419
Kakimoto, Y., & Akazawa, S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62716-4 · Cited by 407
Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase
MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H., Whitley, G. S. J., & Vallance, P. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 393
Self-citationOgawa, T., Kimoto, M., & Sasaoka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81786-0 · Cited by 360
Self-citation
Cited by
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N., McCarey, D. W., Capell, H., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 942
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Self-citationLin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Self-citationAchan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R., & Vallance, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593
Does ADMA Cause Endothelial Dysfunction?
Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2032 · Cited by 581
Self-citationOxidative stress and vascular inflammation in aging
El Assar, M., Angulo, J., & Rodríguez-Mañas, L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.003 · Cited by 575
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553
Behrendt, D., & Ganz, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02963-6 · Cited by 499
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity: Role of Oxidative Stress
Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K.-H., Harrison, D. G., & Tsao, P. S. (2001) · Circulation Research · doi:10.1161/hh1201.092042 · Cited by 485
Self-citationBöger, R. H., Sydow, K., Borlak, J., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode-Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 479
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Sibal, L., C Agarwal, S., D Home, P., & H Boger, R. (2010) · Current Cardiology Reviews · doi:10.2174/157340310791162659 · Cited by 433
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Mann, G. E., Yudilevich, D. L., & Sobrevia, L. (2003) · Physiological Reviews · doi:10.1152/physrev.00022.2002 · Cited by 430
Li, D., & Mehta, J. L. (2000) · Circulation · doi:10.1161/01.cir.101.25.2889 · Cited by 421
Nitric oxide deficiency in chronic kidney disease
Baylis, C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2007 · Cited by 413
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Kleinbongard, P., Heusch, G., & Schulz, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.002 · Cited by 409
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Asymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
Self-citationThe emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
BOGER, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00500-5 · Cited by 393
Kielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 369
Nitric Oxide and Atherosclerosis
Napoli, C., & Ignarro, L. J. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0337 · Cited by 368
Böger, R. H. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2842s · Cited by 363
Janaszak-Jasiecka, A., Płoska, A., Wierońska, J. M., Dobrucki, L. W., & Kalinowski, L. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00423-2 · Cited by 358
Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C., McLaughlin, T., Reaven, G. M., Stuehlinger, M., & Tsao, P. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02063-x · Cited by 354
Self-citationRole of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation
KOFLER, S., NICKEL, T., & WEIS, M. (2005) · Clinical Science · doi:10.1042/cs20040174 · Cited by 353
Arginine metabolism and the synthesis of nitric oxide in the nervous system
Wiesinger, H. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00056-3 · Cited by 352
Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B.-Y., Tsao, P. S., Kimoto, M., Vallance, P., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340
Self-citationThe Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art
Esse, R., Barroso, M., Tavares de Almeida, I., & Castro, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040867 · Cited by 336
Palm, F., Onozato, M. L., Luo, Z., & Wilcox, C. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2007 · Cited by 336
Tran, C. T. L., Leiper, J. M., & Vallance, P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 314
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Oka, R. K., Graf, E. E., Schmölzer, I., Upson, B. M., Kapoor, O., Szuba, A., Malinow, M. R., Wascher, T. C., Pachinger, O., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085067.55901.89 · Cited by 303
Self-citationLeiper, J., Murray-Rust, J., McDonald, N., & Vallance, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212269799 · Cited by 288
Arginine Nutrition and Cardiovascular Function
Wu, G., & Meininger, C. J. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.11.2626 · Cited by 286
Böger, R. H., Bode-Böger, S. M., Sydow, K., Heistad, D. D., & Lentz, S. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1557 · Cited by 278
Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment
PLUTA, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.002 · Cited by 275
Diabetes and Alpha Lipoic Acid
Golbidi, S., Badran, M., & Laher, I. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00069 · Cited by 270
Cooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00034-5 · Cited by 266
Self-citationNIJVELDT, R. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0613 · Cited by 256
Endothelial dysfunction in obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_15 · Cited by 255
Engler, M. M., Engler, M. B., Malloy, M. J., Chiu, E. Y., Schloetter, M. C., Paul, S. M., Stuehlinger, M., Lin, K. Y., Cooke, J. P., Morrow, J. D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086345.09861.a0 · Cited by 253
Self-citationTotal nitric oxide production is low in patients with chronic renal disease
Schmidt, R. J., & Baylis, C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00281.x · Cited by 252
l -Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm
Wilson, A. M., Harada, R., Nair, N., Balasubramanian, N., & Cooke, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.683656 · Cited by 241
Self-citationSympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms
Kaur, J., Young, B., & Fadel, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081682 · Cited by 168
N., C., & J., C. (2002) · Diabetologia · doi:10.1007/s00125-002-0975-6 · Cited by 116
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease
Wang, J., Sim, A. S., Wang, X. L., Salonikas, C., Naidoo, D., & Wilcken, D. E. L. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.002 · Cited by 96
“showed that ADMA decreased NO production by inhibiting NOS in a dose-dependent manner [4].”
BackgroundVascular aging: implications for cardiovascular disease and therapy
Ghebre, Y. T., Yakubov, E., Wong, W. T., & Krishnamurthy, P. (2016) · Translational Medicine · doi:10.4172/2161-1025.1000183 · Cited by 87
“Among the pleiotropic mechanisms of statins and ACE inhibitors in modulating vascular inflammation is the inhibition of circulating TNFα levels [139,140].”
BackgroundInfluentialAspirin reduces endothelial cell senescence
Bode-Böger, S. M., Martens-Lobenhoffer, J., Täger, M., Schröder, H., & Scalera, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.014 · Cited by 85
Ueda, S., Yamagishi, S.-I., Matsumoto, Y., Fukami, K., & Okuda, S. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0471-x · Cited by 65
Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59
Singh, L., Kaur, A., Bhatti, M. S., & Bhatti, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02805-5 · Cited by 55
Wang, W.-L., Shih, Y.-T., Wei, S.-Y., & Chiu, J.-J. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01177-z · Cited by 50
Pluta, R. M., Jung, C. S., Harvey-White, J., Whitehead, A., Shilad, S., Espey, M. G., & Oldfield, E. H. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.4.0731 · Cited by 20
Metadata
- Authors
- Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P.
- Venue
- Circulation
- Published
- 1999-06-22
- Volume
- 99
- Issue
- 24
- Pages
- 3092-3095
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1970798352
- Cited by
- 631
- References
- 17
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.